Opioids for Nonmalignant Pain

Rheumatic Disease Clinics of North America

Volumn 34, Issue 2, 2008, Pages 387-413

  Katz, Warren A ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENN PRESBYTERIAN MEDICAL CENTER   (United States)

^c ROTHMAN INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; BUTORPHANOL; CODEINE; CODEINE PHOSPHATE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DEXTROPROPOXYPHENE; DIHYDROCODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; IBUPROFEN; LEVORPHANOL; METHADONE; MORPHINE; MUSCLE RELAXANT AGENT; NALBUPHINE; NALOXONE; NALTREXONE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; OXYMORPHONE; PARACETAMOL; PENTAZOCINE; PLACEBO; TRAMADOL; UNINDEXED DRUG;

ABDOMINAL PAIN; ALLERGIC REACTION; ANALGESIA; CANCER PAIN; CARDIOVASCULAR DISEASE; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; CONGESTIVE HEART FAILURE; CONSTIPATION; CORONARY ARTERY DISEASE; DIZZINESS; DRUG ABUSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG MEGADOSE; DRUG MISUSE; DRUG POTENTIATION; DRUG SAFETY; DRUG WITHDRAWAL; EDEMA; FIBROMYALGIA; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; HYPERTENSION; ILEUS; INFECTION; KIDNEY DISEASE; KIDNEY FAILURE; LOW BACK PAIN; LUNG TOXICITY; MONOTHERAPY; MUSCULOSKELETAL PAIN; MYOCLONUS; NAUSEA; NAUSEA AND VOMITING; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; OSTEOARTHRITIS; PEPTIC ULCER; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; RESPIRATION DEPRESSION; REVIEW; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SEDATION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; TONIC CLONIC SEIZURE; URINE RETENTION; VOMITING;

ANALGESICS, OPIOID; HUMANS; PAIN; RHEUMATIC DISEASES;

EID: 47349090040     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2008.04.004     Document Type: Review

References (111)

1. American Pain Society. Chronic pain in America: roadblocks to relief. Available at:. http://www.ampainsoc.org/whatsnew/forward_road.htm Accessed March 1, 2008
2. Becker W., Bondegaard N., Thomsen A., et al. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 73 (1997) 393-400
3. Glickman-Simon R. Persistent pain and palliative care. Medscape coverage of the American College of Physicians 2006 Annual Session [Web site]. 2006. Available at: http://www.medscape.com/viewarticle/535720. Accessed January 24, 2007.
4. Siddall P.J., and Cousins M.J. Persistent pain as a disease entity: implications for clinical management. Anesth Analg 99 (2004) 510-520
5. Department of Health and Human Services, National Institutes of Health. New directions in pain research: [Web site]. September 4, 1998. Available at: http://grants.nih.gov/grants/guide/pa-files/PA-98-102.html. Accessed February 21, 2007. It is the third leading cause of absence from work.
6. Katz W.A. Musculoskeletal pain and its socioeconomic implications. Clin Rheumatol 21 (2002) S2-S4
7. Ortho-McNeil Pharmaceutical. 1999 National pain survey [Web site]. 2003. Available at: http://www.chiro.org/LINKS/FULL/1999NationalPainSurvey.html. Accessed February 21, 2007.
8. Allen H., Hubbard D., and Sullivan S. The burden of pain on employee health and productivity at a major provider of business services. J Occup Environ Med 47 (2005) 658-670
9. Stewart W.F., Ricci J.A., Chee E., et al. Lost productive time and cost due to common pain conditions in the US workforce. JAMA 290 (2003) 2443-2454
10. Hu X.H., Markson L.E., Lipton R.B., et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 159 (1999) 813-818
11. Ricci J.A., Stewart W.F., Chee E., et al. Pain exacerbation as a major source of lost productive time in US workers with arthritis. Arthritis Rheum 53 (2005) 673-681
12. Rizzo J.A., Abbott III T.A., and Berger M.L. The labor productivity effects of chronic backache in the United States. Med Care 36 (1998) 1471-1488
13. Barkin R.L., Schwer W.A., and Barkin S.J. Recognition and management of depression in primary care: a focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressants. Am J Ther 7 (2000) 205-226
14. Merskey H. Logic, truth and language in concepts of pain. Qual Life Res 3 Suppl 1 (1994) S69-S76
15. IASP Pain Terminology. Available at:. http://www.iasppain.org/AM/Template.cfm?Section=Pain_Definitions&Tem plate=/CM/HTMLDisplay.cfm&ContentID=1728 Accessed March 15, 2008
16. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis guidelines. Arthritis Rheum 43 (2000) 1905-1915
17. Katz W.A., and Rothenberg R. The importance of improving function in patients with pain. J Clin Rheumatol 11 (2005) S8-S10
18. American Geriatrics Society Panel on Chronic Pain in Older Persons. The management of chronic pain in older persons. J Am Geriatr Soc 46 (1998) 635-651
19. Burton D.G., Allen M.C., Bird J.L., et al. Bridging the gap: ageing, pharmacokinetics and pharmacodynamics. J Pharm Pharmacol 57 (2005) 671-679
20. Elliott T.E., Renier C.M., and Palcher J.A. Chronic pain, depression, and quality of life: correlations and predictive value of the SF-36. Pain Med 4 (2003) 331-339
21. Laursen B.S., Overvad K., Olesen A.S., et al. Ongoing pain, sexual desire, and frequency of sexual intercourse in females with different chronic pain syndromes. Sex Disabil 24 (2006) 27-37
22. McBeth J., Silman A.J., and Macfarlane G.J. Association of widespread body pain with an increased risk of cancer and reduce cancer survival. Mortality: a prospective, population-based study. Arthritis Rheum 48 6 (2003) 1686-1692
23. Sherwood A., Blumenthal J.A., Trivedi R., et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 67 (2007) 367-373
24. Katz W.A. Use of nonopioid analgesics and adjunctive agents in the management of pain in rheumatic diseases. Curr Opin Rheumatol 14 (2002) 63-71
25. Fishman S.M., and Teichera D. Challenges and choices in drug therapy for chronic pain. Cleve Clin J Med 70 (2003) 119-138
26. Maizels M., and McCarberg B. Antidepressants and antiepileptic drugs for chronic non-cancer pain. Am Fam Physician 71 (2005) 483-490
27. Barkin R.L., and Fawcett J. The management challenges of chronic pain: the role of antidepressants. Am J Ther 7 (2000) 31-47
28. Potter M., Schafer S., Gonzalez-Mendez E., et al. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract 50 (2001) 145-151
29. World Health Organization. Cancer pain relief, 2nd ed. With a guide to opioid availability, 1996 availability. 2nd edition (1996), United Nations, World Health Organization, Geneva
30. Furlan A.D., Sandoval J.A., Mailis-Gagnon A., et al. Opioids for chronic noncancer pain: a metaanalysis of effectiveness and side effects. CMAJ 174 11 (2006) 1589-1594
31. Turk D.C., Brody M.C., and Okifuji E.A. Physicians' attitudes and practices regarding the long-term prescribing of opioids for non-cancer pain. Pain 59 (1994) 201-208
32. Passik S.D., and Weinreb H.J. Managing chronic malignant pain: overcoming obstacles to the use of opioids. Adv Ther 17 (2000) 70-83
33. Glajchen M. Chronic pain: treatment barriers and stategies for clinical practice. J Am Board Fam Pract 14 (2001) 211-218
34. Portnoy R.K., and Foley K.M. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 25 (1986) 171-186
35. Ekman E.F., and Korman L.A. Acute pain following musculoskeletal injuries and orthopaedic surgery: mechanisms' and management. Instr Course Lect 54 (2005) 21-33
36. Simpson K.H. Opioids for persistent non-cancer pain: recommendations for clinical practice. Br J Anaesth 92 3 (2004) 326-328
37. Turk D.C., and Okifuji A. What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain. Clin J Pain 13 (1997) 330-336
38. Yaksh T.L., Hua X.Y., Kalcheva I., et al. The spinal biology in humans and animals of pain states generated by persistent small afferent input. Proc Natl Acad Sci 96 (1999) 7680-7686
39. Grahmann P.H., Jackson K.C., and Lipman A.G. Clinical beliefs about opioid use and barriers in chronic nonmalignant pain. J Pain Palliat Care Pharmacother 18 2 (2004) 7-28
40. DURAGESIC. Fentanyl transdermal system. [package insert] (2005), Janssen Pharmaceutical Products, LP, Titusville (NJ)
41. ULTRAM. Tramadol hydrochloride tablets. [package insert] (2004), Ortho-McNeil Pharmaceutical, Raritan (NJ)
42. Gutstein H.B., and Akil H. Opioid analgesics. In: Brunton L., Lazo J.S., and Parker K.L. (Eds). Goodman & Gilman's the pharmacological basis of therapeutics (2006), McGraw-Hill, New York 547-590
43. Barkin R.L., Lubenow T.R., Bruehl S., et al. Management of chronic pain: part I. Dis Mon 42 (1996) 389-454
44. Cherny N.I. Opioid analgesics: comparative features and prescribing guidelines. Drugs 51 (1996) 713-737
45. Avouac J., Gossec L., and Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 15 8 (2007) 957-965
46. Caudill-Slosberg M.A., Schwartz L.M., and Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain 109 3 (2004) 514-519
47. Goodwin J.K., Kraemer J.J., and Bajwa Z.H. The use of opioids in the treatment of osteoarthritis: when, why, and how?. Curr Pain Headache Rep 9 6 (2005) 360-368
48. Griessinger N., Sittl R., Jost R., et al. The role of opioid analgesics in rheumatoid disease in the elderly population. Drugs Aging 20 8 (2003) 571-583
49. Available at:. http://www.news-medical.net/print_article.asp?id=30532 Accessed March 16, 2008
50. Solomon D.H., Avorn J., Wang P.S., et al. Prescription opioid among older adults with arthritis or low back pain. Arthritis Rheum 55 1 (2006) 35-41
51. Fanciullo G.J., Ball P.A., Girault G., et al. An observational study on the prevalence and pattern of opioid use in 25,479 patients with spine and radicular pain. Spine 27 (2002) 201-205
52. Martell B.A., O'Connor P.G., Kerns R.D., et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 146 2 (2007) 116-127
53. Available at:. http://www.ama-cmeonline.com/pain_mgmt/ Accessed March 1, 2008
54. Burgess F.W., Krantz M.J., and Barkin R.L. Methadone: unintended mortality due to overdose and arrhythmia. Pain Medicine News (2007 (May/June)) 1-6
55. Barkin R.I., Barkin S.J., and Barkin D.S. Propoxyphene (dextropropoxyphene): a critical review of a weak opioid analgesic that should remain in antiquity. Am J Ther 13 (2006) 534-542
56. Wang D., and Teichtahl H. Opioids sleep architecture and sleep-disordered breathing. Sleep Med Rev 11 1 (2007) 35-46
57. Zhang W., Moskowitz R.W., Nuki G., et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthr Cartil 16 (2008) 137-162
58. Zhang W., Doherty M., Arden N., et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis 64 (2005) 669-681
59. Katz W.A., Schnitzer T.J., Almekinders L.C., et al. Emerging paradigms on the management of musculoskeletal pain: focus on osteoarthritis and low back pain. Clinical Courier 24 34 (2006) 1-10
60. Straub R.H., Wolff C., Fassold A., et al. Anti-inflammatory role of endorphins in osteoarthritis, rheumatoid arthritis and adjuvant-induced poly arthritis. Arthritis Rheum 58 2 (2008) 456-466
61. Dominick K.L., Bosworth H.B., Dudley T.K., et al. Patterns of opioid analgesic prescription among patients with osteoarthritis. J Pain Palliat Care Pharmacother 18 1 (2004) 31-46
62. Bjordal J.M., Klovning A., Ljunggren A.E., et al. Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: a meta-analysis of randomized placebo-controlled studies. Eur J Pain 11 2 (2007) 125-138
63. Peloso P.M., Bellamy N., Bensen W., et al. Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol 27 3 (2000) 764-771
64. Markenson J.A., Croft J., Zhang P.G., et al. Treatment of persistent pain associated with osteoarthritis with controlled-release oxycodone tablets in a randomized controlled study. Clin J Pain 21 6 (2005) 524-535
65. Matsumoto A.K., Babul N., and Ahdieh H. Oxymorphone extended-release tablets relieve moderate to severe pain and improve physical function in osteoarthritis: results of a randomized, double-blind, placebo- active-controlled phase III trial. Pain Med 6 5 (2005) 357-366
66. Langford R., McKenna F., Ratcliffe S., et al. Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo controlled trial. Arthritis Rheum 54 6 (2006) 1829-1837
67. Cepeda M.S., Camargo F., Zea C., et al. Tramadol for osteoarthritis: a systematic review and metaanalysis. J Rheumatol 34 3 (2007) 543-555
68. Adler L., McDonald C., O'Brien C., et al. A comparison of one-daily tramadol with normal release tramadol in the treatment of pain in osteoarthritis. J Rheumatol 29 10 (2002) 2196-2199
69. Malone F., Coffiner M., Soonet B., et al. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 26 11 (2004) 1174-1182
70. Babul N., Noveck R., Chipman H., et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis. J Pain Symptom Manage 28 1 (2004) 59-71
71. Pavelka K., Le Loet X., Bjorneboe O., et al. Benefits of transdermal fentanyl inpatients with rheumatoid arthritis or osteoarthritis of the knee or hip: an open label study to assess pain control. Curr Med Res Opin 20 12 (2004) 1967-1977
72. Herrero-Beaumont G., Bjorneboe O., and Richarz U. Transdermal fentanyl for the treatment of pain caused by rheumatoid arthritis. Rheumatol Int 24 6 (2004) 325-332
73. Lee E.Y., Lee E.B., Park B.J., et al. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week study, randomized, double-blind, placebo-controlled trial. Clin Ther 28 12 (2006) 2052-2060
74. Parkhill A., and Bidlack J.M. Reduction of lipopolysaccharide-induced interleukin-6 production by kappa opioid U50,488 in a mouse monocyte-like cell line. Int Immunopharmacol 6 6 (2006) 1013-1019
75. Walker J.S. Anti-inflammatory effects of opioids. Adv Exp Med Biol 521 (2003) 148-150
76. Kalso E, Perrot S. On behalf of the Chronic Low Back Pain Panel. Recommendations on the use of strong opioids in low back pain before it becomes chronic. EULAR 2005. Vienna (Austria), June 8-11, 2005. [Abstract SAT0360]. Available at: http://www.medscape.com/viewarticle/538250_print. Accessed March 10, 2008.
77. Deshpande A., Furlan A., Mailis-Gagnon A., et al. Opioids for chronic low-back pain. Cochrane Database Syst Rev 3 (2007) 10.1002/14651858.CD004959.pub3 CD004959
78. Portenoy R.K., Messina J., Xie F., et al. Fentanyl buccal (FBT) for relief of breakthrough pain in opioid-treated patients with chronic low back pain: a randomized placebo-controlled study. Curr Med Res Opin 23 1 (2007) 223-233
79. Wallace M., Skowronski R., Khanna S., et al. Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study. Curr Med Res Opin 23 5 (2007) 981-989
80. Hale M.E., Ahdieh H., Ma T., et al. Efficacy and safety of OPANA ER (oxymorphone extended release) for the relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study. J Pain 8 2 (2007) 175-184
81. Raber M., Hofmann S., Junge K., et al. Analgesic efficacy and tolerability of tramadol 100 mg sustained-release capsules in patients with moderate to severe chronic low back pain. Clinical Drug Investigation 17 6 (1999) 415-423
82. Harris R.E., Clauw D.J., Scott D.J., et al. Decreased central μ-opioid receptor availability in fibromyalgia. J Neurosci 27 (2007) 10000-10006
83. Wolfe F., Anderson J., Harkness D., et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 40 (1997) 1560-1570
84. Kemple K.L., Smith G., and Wong-Ngan J. Opioid therapy in fibromyalgia-A four-year prospective evaluation of therapy selection, efficacy, and predictions of outcome. Arthritis Rheum 48 (2003) S88
85. Chu L.F., Clark D.J., and Angst M.S. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 7 (2006) 43-48
86. Russell I.J., Kamin M., Bennett R.M., et al. Efficacy of tramadol in treatment of pain of fibromyalgia. J Clin Rheumatol 6 (2000) 250-257
87. Bennett R.M., Kamin M., Karim R., et al. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind randomized, placebo-controlled study. Am J Med 113 (2003) 537-545
88. Barkin R.I., and Barkin D. Pharmacologic management of acute and chronic pain; focus on drug interactions and patients-specific pharmacotherapeutic selection. South Med J 18 (2001) 790-804
89. Katz W.A., Otis J.A.D., McCarberg B., et al. Pain management: balancing efficacy with safety and tolerability. Clinical Courier 25 10 (2007) 1-10
90. Drake M.J., Nixon P.M., and Crew J.P. Drug-induced bladder and urinary disorders: incidence, prevention and management. Drug Saf 19 1 (1998) 45-55
91. Jovanovi-Cupi V., Martinovi Z., and Nesi N. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol (Phila) 44 2 (2006) 143-146
92. Byas-Smith M.G., Chapman S.L., Reed B., et al. The effect of opioids on driving and psychomotor performance in patients with chronic pain. Clin J Pain 21 4 (2005) 345-352
93. Gaertner J., Radbruch L., Giesecke T., et al. Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients. Acta Anaesthesiol Scand 50 6 (2006) 664-672
94. Abs R., Verhelst J., Van Buyten J., et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endorcrinol Metab 85 (2000) 2215-2222
95. Deardorf W. Breaking the cycle of chronic pain and insomnia. [Web site]. August 23, 2005. Available at: http://www.spine-health.com/topics/conserv/nsomnia/insomnia1.html. Accessed February 10, 2008.
96. Roehrs T., and Roth T. Sleep and pain: interaction of two vital functions. Semin Neurol 25 1 (2005) 106-116
97. Onen S.H., Onen F., Courpron P., et al. How pain and analgesics disturb sleep. Clin J Pain 21 5 (2005) 422-431
98. Available at:. http://www.painmed.org/pdf/definition.pdf Accessed March 1, 2008
99. Available at:. http://www.ampain.org/advocacy/opioids.htm Accessed March 1, 2008
100. Available at:. http://www.emedicine.com/med/topic1673.htm Accessed March 1, 2008
101. Ballantyne J.C., and Mao J. Opioid therapy for chronic pain. N Engl J Med 349 (2003) 1943-1953
102. Available at:. http://www.ama-cmeonline.com/pain_mgmt/module04/index.htm Accessed March 1, 2008
103. Bloodworth D. Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations. Phys Med Rehabil Clin N Am 17 2 (2006) 355-379
104. Chan K.T., and Fishman S.M. Legal aspects of chronic opioid therapy. Curr Pain Headache Rep 10 6 (2006) 426-430
105. Wilsey B., Fishman D.M., Rose J.S., et al. Pain management in the ED. Am J Emerg Med 221 1 (2004) 51-57
106. Rupp T., and Dekaney K.A. Inadequate analgesia in emergency medicine. Ann Emerg Med 43 4 (2004) 494-503
107. Hoffman D.E., and Tarzian A.J. Achieving the right balance in oversight of physician opioid prescribing for pain: The role of state medical boards. J Law Med Ethics 31 (2003) 21-40
108. Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 3 (2004) CD004847
109. Clinical practice guidelines for the management of opioid therapy for chronic pain. Appendix E. Mar.2003. Washington, DC. Available at: http://www.ihs.gov/NonMedicalPrograms/NC4/Documents/Chronicpainguideline sVA2003.pdf.
110. American Medical Association. Pain management: Part 3. Management of persistent nonmalignant pain. 2006.
111. Katz WA, Barkin RL. Dilemmas in chronic/persitent pain management. Am J Ther, accepted for publication.